Ethical Criteria for Human Challenge Studies in Infectious Diseases
- PMID: 29731811
- PMCID: PMC5926904
- DOI: 10.1093/phe/phv026
Ethical Criteria for Human Challenge Studies in Infectious Diseases
Abstract
Purposeful infection of healthy volunteers with a microbial pathogen seems at odds with acceptable ethical standards, but is an important contemporary research avenue used to study infectious diseases and their treatments. Generally termed 'controlled human infection studies', this research is particularly useful for fast tracking the development of candidate vaccines and may provide unique insight into disease pathogenesis otherwise unavailable. However, scarce bioethical literature is currently available to assist researchers and research ethics committees in negotiating the distinct issues raised by research involving purposefully infecting healthy volunteers. In this article, we present two separate challenge studies and highlight the ethical issues of human challenge studies as seen through a well-constructed framework. Beyond the same stringent ethical standards seen in other areas of medical research, we conclude that human challenge studies should also include: (i) independent expert reviews, including systematic reviews; (ii) a publicly available rationale for the research; (iii) implementation of measures to protect the public from spread of infection beyond the research setting; and (iv) a new system for compensation for harm. We hope these additions may encourage safer and more ethical research practice and help to safeguard public confidence in this vital research alternative in years to come.
References
-
- Academy of Medical Sciences . ( 2005. ). Microbial Challenge Studies of Human Volunteers . London: : The Academy of Medical Sciences; .
-
- Agnandji S. T., Lell B., Soulanoudjingar S. S., Fernandes J. F., Abossolo B. P., Conzelmann C., Methogo B. G., Doucka Y., Flamen A., Mordmuller B., Issifou S., Kremsner P. G., Sacarlal J., Aide P., Lanaspa M., Aponte J. J., Nhamuave A., Quelhas D., Bassat Q., Mandjate S., Macete E., Alonso P., Abdulla S., Salim N., Juma O., Shomari M., Shubis K., Machera F., Hamad A. S., Minja R., Mtoro A., Sykes A., Ahmed S., Urassa A. M., Ali A. M., Mwangoka G., Tanner M., Tinto H., D’alessandro U., Sorgho H., Valea I., Tahita M. C., Kabore W., Ouedraogo S., Sandrine Y., Guiguemde R. T., Ouedraogo J. B., Hamel M. J., Kariuki S., Odero C., Oneko M., Otieno K., Awino N., Omoto J., Williamson J., Muturi-kioi V., Laserson K. F., slutsker L., Otieno W., Otieno L., Nekoye O., Gondi S., Otieno A., Ogutu B., Wasuna R., Owira V., Jones D., Onyango A. A., Njuguna P., Chilengi R., Akoo P., Kerubo C., Gitaka J., Maingi C., Lang T., Olotu A., Tsofa B., Bejon P., Peshu N., Marsh K., Owusu-agyei S., Asante K. P., Osei-kwakye K., Boahen O., Ayamba S., Kayan K., Owusu-ofori R., Dosoo D., Asante I., Adjei G., Adjei G., Chandramohan D., Greenwood B., Lusingu J., Gesase S., Malabeja A., Abdul O., Kilavo H., Mahende C., Liheluka E., et al. . ( 2011. ). First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children . The New England Journal of Medicine , 365 , 1863 – 1875 . - PubMed
-
- Centers for Disease Control and Prevention . ( 2013. ). Smallpox Disease Overview [Online], available from: http://www.bt.cdc.gov/agent/smallpox/overview/disease-facts.asp [accessed 15 September 2013] .
-
- Church L. W., Le T. P., Bryan J. P., Gordon D. M., Edelman R., Fries L., Davis J. R., Herrington D. A., Clyde D. F., Shmuklarsky M. J., Schneider I., Mcgovern T. W., Chulay J. D., Ballou W. R., Hoffman S. L. ( 1997. ). Clinical Manifestations of Plasmodium Falciparum Malaria Experimentally Induced by Mosquito Challenge . The Journal of Infectious Diseases , 175 , 915 – 920 . - PubMed
-
- Cohen B. ( 1990. ). The Ethics of Using Medical Data from Nazi Experiments . Journal of Halacha and Contemporary Society , 19 , 103 – 126 . - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
